Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (Q34556870)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q6087190)
(P304) 1389-1397
(P407) (Q1860)
(P433) 9468
(P478) 365
(P577) Friday, April 1, 2005
(P921) (Q181600)
(Q17907844)
(Q422936)
(Q421237)
(Q12174)
(Q11068)
(P1433) (Q939416)
(P1476) "Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study" (language: en)
(P2093) Luc F Van Gaal
Aila M Rissanen
André J Scheen
Olivier Ziegler
RIO-Europe Study Group
(P2860) (Q34323455)
(Q80946147)
(Q35169067)
(Q35876026)
(Q28211969)
(Q35028193)
(Q28575514)
(Q34355485)
(Q44193713)
(Q44205907)
(Q44279121)
(Q39793318)
(Q34431882)
(Q61479731)
(Q63694274)
(Q26776977)
(Q27860968)
(Q52031816)
(Q34301193)
(Q33804631)
(Q34496492)
(Q28240076)
(Q28298338)
(Q34159121)
(Q35639524)
(Q38333962)
(Q48664473)
(Q28505765)
(Q28366672)
(Q28506782)
(Q28281870)
(Q44527080)
(Q44418730)
other details
description scientific article

External Links